Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interstitial lung disease and gefitinib.

× No keyword cloud information.

7 in total

1. Pulmonary alveolar hemorrhage possibly associated with lenalidomide use.

Authors: Yasuo Oshima; Arinobu Tojo
Journal: Int J Hematol Date: 2011-08-20 Impact factor: 2.490

2. Attractive tools for systematic case accumulation.

Authors: Yasuo Oshima; Arinobu Tojo
Journal: Int J Hematol Date: 2011-08-30 Impact factor: 2.490

Review 3. Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.

Authors: Rashmi R Shah
Journal: Drug Saf Date: 2016-11 Impact factor: 5.606

Review 4. A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors: Tetsuya Tanimoto
Journal: Drug Des Devel Ther Date: 2015-03-31 Impact factor: 4.162

5. A Case of Squamous Cell Carcinoma of Unknown Primary that Responded to the Multi-Tyrosine Kinase Inhibitor Lenvatinib.

Authors: Reiko Kimura-Tsuchiya; Eisaku Sasaki; Izumi Nakamura; Satoshi Suzuki; Satoshi Kawana; Chiyo Okouchi; Toshihiko Fukushima; Yuko Hashimoto; Shinichi Suzuki; Shigehira Saji
Journal: Case Rep Oncol Date: 2018-02-09

Review 6. The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients.

Authors: Xiaoyang Zhai; Jian Zhang; Yaru Tian; Ji Li; Wang Jing; Hongbo Guo; Hui Zhu
Journal: Cancer Biol Med Date: 2020-08-15 Impact factor: 4.248

7. Tumor invasion in the central airway is a risk factor for early-onset checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer.

Authors: Mitsuhiro Moda; Haruhiro Saito; Terufumi Kato; Ryo Usui; Tetsuro Kondo; Yoshiro Nakahara; Shuji Murakami; Kouji Yamamoto; Kouzo Yamada
Journal: Thorac Cancer Date: 2020-10-20 Impact factor: 3.500

7 in total